Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyModa Health Disc Prosthesis Coverage Update | Open…
    Ask Trek AI about this page
    ModifiedModa HealthPolicy N/A

    Intervertebral Disc Prosthesis

    Customize your policy alerts

    Sign up for all Moda Health policy alerts

    Know when Moda Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Moda Health medical necessity and prior authorization requirements for cervical and lumbar total disc arthroplasty, including eligible FDA-approved devices, clinical criteria, contraindications, documentation, and applicable procedure and diagnosis codes. It applies to providers requesting coverage for intervertebral disc prosthesis procedures.

    Policy Summary
    PayerModa Health
    PolicyIntervertebral Disc Prosthesis
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateJun 1, 2026
    Last ReviewMay 27, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization with treating physician chart notes, radiographic studies, conservative-treatment documentation, and the requested artificial disc type.
    SourceLink
    POLICY UPDATE CHANGES

    The artificial disc FDA approval appendix adds Baguera C as FDA approved for one- and two-level cervical use and PCM as FDA approved for single-level cervical use.

    C3-C7Cervical treatment range
    1 level

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Maximum lumbar replacement
    2 levelsMaximum cervical replacement
    6 monthsImaging age limit
    ExperimentalOther indications

    Medical Necessity and Coverage Criteria

    Cervical disc arthroplasty

    FDA-approved cervical prosthetic discs are covered to plan limitations when ALL of the following are met.

    Cervical eligibility

    • Imaging and diagnosis: MRI or CT performed within the last 6 months confirms degenerative disc disease with severe spinal stenosis, cord compression, or nerve root compression, with a herniated disc or spondylosis defined by osteophytes.Imaging <=6 months
    • Symptoms and conservative treatment: Neck pain of discogenic origin or radiculopathy has not responded to at least 2 months of conservative treatment, including at least 2 of the following: NSAIDs, analgesics, or steroids; physical therapy; or epidural steroid injection/selective nerve root blocks with less than clinically meaningful improvement.>=2 months and >=2 treatment categories

      The time frame may be waived for progressive neurological worsening despite nonoperative treatment.

    • Surgical history and level planning: There has been no previous surgical intervention at the involved level or levels, and no procedure is planned at an adjacent level.No prior involved-level surgery; no adjacent-level procedure planned
    • Smoking status: The patient is a nonsmoker, or is a documented smoker who has abstained from tobacco for at least 6 weeks before surgery with laboratory evidence of nicotine-free status by cotinine level.>=6 weeks abstinence if smoker
    • Behavioral health: Significant mental or behavioral disorders, such as chronic pain syndrome, alcohol use disorders, or major depressive disorder, are managed.Management documented
    • Contraindications absent: None of the policy contraindications are present, including treatment of more than one or two cervical levels, an adjacent fused or planned fusion level, cervical instability exceeding the stated radiographic thresholds, osteoporosis, osteopenia, osteomalacia, spinal metastases, severe facet disease, active systemic infection, allergy to implant materials, chronic steroid use, pregnancy, or morbid obesity.

    Lumbar disc arthroplasty

    FDA-approved lumbar prosthetic intervertebral discs are covered to plan limitations when ALL of the following are met.

    Lumbar eligibility

    • Lumbar conservative treatment: Low back pain has not responded to at least 6 months of conservative treatment including all of the following: NSAIDs, analgesics, or steroids; physical therapy; and epidural steroid injections/selective nerve root blocks.>=6 months and all listed treatment categories

      The time frame may be waived for progressive neurological worsening despite nonoperative treatment.

    • Surgical candidacy and prior fusion: The patient is a candidate for spine surgery, such as fusion, and has no prior lumbar spinal fusion.Surgical candidate; no prior lumbar fusion
    • Smoking status:

    Experimental and investigational services

    Limitations apply to all requests.

    Investigational limitation: The requested intervertebral disc device is being studied in a clinical trial, or the requested indication is not one of the covered eligible FDA-approved cervical or lumbar disc replacement indications described in this policy.Clinical-trial device or other indication

    The prosthesis itself is investigational and is not covered when it is being studied in a clinical trial. All other indications for prosthetic intervertebral disc prosthesis are experimental and investigational.

    Cervical disc prosthesis is not covered when treatment involves more than one or two cervical levels, an adjacent level is fused, or fusion is planned at an adjacent level. Coverage is also excluded for cervical instability exceeding 3.5 mm of sagittal-plane translation or 20 degrees of sagittal-plane angulation at a single level; osteoporosis, osteopenia, or osteomalacia; spinal metastases; severe facet joint disease; active systemic infection; allergy or sensitivity to stainless steel, titanium, or titanium alloy; chronic steroid use; pregnancy; or morbid obesity.

    Lumbar disc prosthesis is not covered for previous lumbar fusion or planned simultaneous multilevel implantation. Other noncovered circumstances include osteoporosis or osteopenia; active systemic or implantation-site infection; spinal tumor; multilevel degenerative disc disease; Grade 2 or greater degenerative spondylolisthesis; pars interarticularis defect with spondylolysis or isthmic spondylolisthesis; facet ankylosis or severe facet arthrosis; nerve root compression or lumbar spinal stenosis; lumbar scoliosis; spinal fracture; chronic steroid use; pregnancy; morbid obesity; or allergy or sensitivity to cobalt, chromium, molybdenum, polyethylene, or titanium.

    The requested prosthesis is considered investigational and not covered when the device is being studied in a clinical trial; the cost of the artificial disc is generally paid by the trial. All other indications for prosthetic intervertebral disc replacement, beyond the eligible FDA-approved cervical and lumbar indications described in this policy, are considered experimental and investigational.

    Procedure, Diagnosis, and Clinical Coding Details

    Covered CPT CodesCPTCovered
    22856Total disc arthroplasty (artificial disc), anterior approach, including discectomy with end plate preparation (includes osteophytectomy for nerve root or spinal cord decompression and microdissection), single interspace, cervical
    22857Total disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression), single interspace, lumbar
    22858Total disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression), second interspace, cervical
    22860Total disc arthroplasty (artificial disc), anterior approach, including discectomy to prepare interspace (other than for decompression); second interspace, lumbar; list separately in addition to code for primary procedure
    22861Revision including replacement of total disc arthroplasty (artificial disc), anterior approach, single interspace; cervical
    22862Revision including replacement of total disc arthroplasty (artificial disc), anterior approach, single interspace; lumbar
    22864Removal of total disc arthroplasty (artificial disc), anterior approach, single interspace; cervical
    22865Removal of total disc arthroplasty (artificial disc), anterior approach, lumbar
    0095TRemoval of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical; list separately in addition to code for primary procedure
    0098TRevision including replacement of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical; list separately in addition to code for primary procedure
    1–10 of 12
    1/2
    Applicable ICD-10 CodesICD-10
    G54.2Cervical root disorders, not elsewhere classified [nerve root/spinal cord compression]
    G54.9Nerve root and plexus disorder, unspecified [nerve root/spinal cord compression]
    M50.00-M50.03Cervical disc disorder with myelopathy [nerve root/spinal cord compression]
    M50.10-M50.13Cervical disc disorder with radiculopathy [nerve root/spinal cord compression]
    M50.20-M50.23Other cervical disc displacement
    M50.30-M50.33Other cervical disc degeneration
    M51.36Other intervertebral disc degeneration, lumbar region
    M51.37Other intervertebral disc degeneration, lumbosacral region
    M53.1Cervicobrachial syndrome [with findings of weakness, myelopathy, or sensory deficit]
    Cervical treatment levels
    Eligible cervical rangeBetween C3 and C7
    Permitted treatment levelsOne or two contiguous levels
    Device requirementFDA-approved cervical device
    Cervical imaging age
    Accepted imagingMRI or CT scan
    Imaging recencyPerformed within the last 6 months
    Required imaging evidence

    Prior Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Required

    Submit a prior authorization request for intervertebral disc prosthesis surgery before treatment. The request must include the clinical records needed to establish that the applicable cervical or lumbar coverage criteria are met.

    Step Therapy

    Cervical Conservative Treatment

    For cervical disc replacement, document neck pain of discogenic origin or radiculopathy that has not responded to at least 2 months of conservative treatment. The time requirement may be waived when progressive neurological worsening continues despite nonoperative treatment.

    • Document at least 2 of the following treatment modalities: NSAIDs, analgesics, or steroids; physical therapy; and epidural steroid injection or selective nerve root blocks with less than clinically meaningful improvement.
    Step Therapy

    Clinical Background

    Total disc arthroplasty replaces a damaged intervertebral disc after discectomy with a prosthetic device intended to preserve motion at the operative level and restore or maintain segment biomechanics. In selected patients with cervical or lumbar degenerative disc disease or disc herniation, it may serve as an alternative to spinal fusion or discectomy. Long-term outcomes remain under study, including the potential for adjacent-disc or facet degeneration and polyethylene wear that may require revision surgery.

    Key Terms and Covered Disease

    Total disc arthroplasty
    ProcedureReplacement of a damaged intervertebral disc
    Replacement deviceA prosthetic intervertebral disc
    Intended functionMaintain motion at the operative spinal level
    Covered cervical disease
    Eligible diseaseDegenerative cervical disc disease or disc herniation
    Eligible levelsOne or two contiguous levels between C3 and C7
    Imaging evidenceSevere spinal stenosis, cord compression, or nerve root compression, with a herniated disc or osteophyte-defined spondylosis
    Policy Summary
    PayerModa Health
    PolicyIntervertebral Disc Prosthesis
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateJun 1, 2026
    Last ReviewMay 27, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization with treating physician chart notes, radiographic studies, conservative-treatment documentation, and the requested artificial disc type.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaProcedure, Diagnosis, and Clinical Coding DetailsPrior Authorization and Documentation RequirementsClinical BackgroundKey Terms and Covered Disease
    The patient is a nonsmoker, or is a documented smoker who has abstained from tobacco for at least 6 weeks before surgery with laboratory evidence of nicotine-free status by cotinine level.
    >=6 weeks abstinence if smoker
  1. Behavioral health: Significant mental or behavioral disorders, such as chronic pain syndrome, alcohol use disorders, or major depressive disorder, are managed.Management documented
  2. Contraindications absent: None of the policy contraindications are present, including previous lumbar fusion, planned simultaneous multilevel implantation, osteoporosis or osteopenia, infection, spinal tumor, multilevel degenerative disc disease, Grade 2 or greater degenerative spondylolisthesis, pars interarticularis defect with spondylolysis or isthmic spondylolisthesis, facet ankylosis or severe facet arthrosis, nerve root compression or lumbar spinal stenosis, lumbar scoliosis, spinal fracture, chronic steroid use, pregnancy, morbid obesity, or allergy or sensitivity to cobalt, chromium, molybdenum, polyethylene, or titanium.
  3. Severe spinal stenosis, cord compression, or nerve root compression, with a herniated disc or osteophyte-defined spondylosis
    Cervical conservative treatment
    Minimum treatment durationAt least 2 months of conservative treatment
    Treatment responseNeck pain of discogenic origin or radiculopathy has not responded with clinically meaningful improvement
    ExceptionThe time frame may be waived for progressive neurological worsening despite nonoperative treatment
    Cervical instability
    Sagittal-plane translationGreater than 3.5 mm at a single level
    Sagittal-plane angulationGreater than 20 degrees at a single level
    Coverage implicationCervical disc replacement is not covered when either instability threshold is exceeded
    Lumbar treatment level
    Permitted treatment levelsOne level
    Eligible levelsL3-4, L4-5, or L5-S1
    Degenerative disc diseaseMust be limited to the single involved level
    Lumbar imaging age
    Accepted imagingCT scan or MRI
    Imaging recencyWithin the last 6 months
    PurposeConfirmation of degenerative disc disease at the involved lumbar level
    Lumbar conservative treatment
    Minimum treatment durationAt least 6 months of conservative treatment
    Required treatment categoriesNSAIDs, analgesics, steroids, physical therapy, and epidural steroid injections or selective nerve root blocks
    ExceptionThe time frame may be waived for progressive neurological worsening despite nonoperative treatment
    Lumbar spondylolisthesis
    Maximum permitted gradeNo more than Grade I
    Applicable siteThe involved lumbar level
    Noncovered thresholdGrade 2 or greater degenerative spondylolisthesis
    Smoking abstinence
    Non-smoker optionThe patient may meet the smoking criterion as a non-smoker
    Required abstinenceAt least 6 weeks before surgery
    Laboratory documentationNicotine-free status documented by cotinine level

    Lumbar Conservative Treatment

    For lumbar disc replacement, document low back pain that has not responded to at least 6 months of conservative treatment. The time requirement may be waived when progressive neurological worsening continues despite nonoperative treatment.

    • Document all of the following treatment modalities: NSAIDs, analgesics, or steroids; physical therapy; and epidural steroid injections or selective nerve root blocks.
    Documentation Required

    Prior Authorization Documentation

    Include the treating physician’s chart notes with the prior authorization request. Supporting records must address the patient’s clinical history, radiographic evaluation, conservative treatment attempts, and the specific artificial disc requested.

    • Chart notes from the treating physician
    • Radiographic studies
    • Records of conservative treatment attempts
    • Type of artificial disc or intervertebral disc prosthesis requested
    Documentation Required

    Clinical Criteria Evidence

    Provide documentation demonstrating every applicable clinical coverage criterion for the requested device and spinal region.

    • Cervical requests: patient age 18 or older and skeletal maturity; degenerative cervical disc disease or disc herniation at only 1 or 2 contiguous levels between C3-C7; planned single- or two-level replacement with an FDA-approved device; MRI or CT performed within the last 6 months confirming degenerative disc disease with severe spinal stenosis, cord compression, or nerve root compression, with herniated disc or spondylosis; no prior surgery at the involved level or planned adjacent-level procedure; smoking status or documented nicotine-free abstinence for at least 6 weeks; and management of significant mental or behavioral disorders.
    • Lumbar requests: skeletal maturity; degenerative disc disease at only one level (L3-4, L4-L5, or L5-S1) confirmed by history and CT or MRI within the last 6 months; planned one-level replacement; no more than Grade I spondylolisthesis; candidacy for spine surgery; no prior lumbar fusion; smoking status or documented nicotine-free abstinence for at least 6 weeks; and management of significant mental or behavioral disorders.
    • Document the applicable diagnosis, operative level(s), imaging findings, FDA-approved device, conservative treatment history, smoking status, and other clinical findings supporting medical necessity.
    Denial Risk

    Cervical Contraindications

    Cervical disc prosthesis is not covered when any listed cervical contraindication or exclusion is present.

    • More than 1 or 2 cervical levels require surgical treatment.
    • A fused level is adjacent to the treatment level, or fusion at an adjacent level is planned with disc replacement.
    • Dynamic flexion-extension radiographs show cervical instability, sagittal-plane translation greater than 3.5 mm, or sagittal-plane angulation greater than 20 degrees at a single level.
    • Osteoporosis, osteopenia, osteomalacia, spinal metastases, severe facet joint disease at the involved level, active systemic infection, chronic steroid use, pregnancy, or morbid obesity.
    • Known allergy or sensitivity to stainless steel, titanium, or a titanium alloy.
    Denial Risk

    Lumbar Contraindications

    Lumbar disc prosthesis is not covered when any listed lumbar contraindication or exclusion is present.

    • Previous lumbar fusion or simultaneous multilevel implantation is planned.
    • Osteoporosis or osteopenia.
    • Imaging confirms active systemic or localized infection, spinal tumor, multiple levels of degenerative disc disease, Grade II or greater degenerative spondylolisthesis, pars interarticularis defect with spondylolysis or isthmic spondylolisthesis, facet ankylosis or severe facet arthrosis, nerve root compression or lumbar spinal stenosis, lumbar scoliosis, or spinal fracture.
    • Chronic steroid use, pregnancy, or morbid obesity.
    • Known allergy or sensitivity to cobalt, chromium, molybdenum, polyethylene, or titanium.
    Denial Risk

    Investigational Indications and Devices

    Intervertebral disc devices being studied in a clinical trial are reviewed case by case for the surgery authorization request, but the investigational artificial disc itself is not covered by Moda Health; the trial generally pays for the device. All other indications for prosthetic intervertebral disc replacement are considered experimental and investigational.

    • Identify whether the requested device is being studied in a clinical trial.
    • Do not represent the clinical-trial device itself as a covered Moda Health benefit.
    • All indications outside the policy’s covered cervical and lumbar criteria are experimental and investigational.